Pulmonary manifestations of systemic lupus erythematosus (SLE) are wide-ranging and
debilitating in nature. Previous studies suggest that anywhere between 20 and 90% of …

Cardiac arrhythmias are a significant cause of morbidity and mortality worldwide, accounting
for 10% to 15% of all deaths. Although most arrhythmias are due to acquired heart disease …

Pulmonary complications in CTD are common and can involve the interstitium, airways,
pleura and pulmonary vasculature. ILD can occur in all CTD (CTD‐ILD), and may vary from …

Objective Immune-mediated inflammatory diseases (IMIDs) are heterogeneous and complex
conditions with overlapping clinical symptoms and elevated familial aggregation, which …

Pulmonary Hypertension (PH) is a common manifestation in patients with Systemic Lupus
Erythematosus (SLE) and varies from asymptomatic to life-threatening disease. PH can …

Disease modification has become a well-established concept in several therapeutic areas;
however, no widely accepted definition of disease modification exists for SLE. We reviewed …

Background Bacterial infections of the lung, skin, bloodstream and other tissues are
common in patients with systemic lupus erythematosus (lupus) and are often more severe …

Abstract Introduction Connective Tissue Diseases (CTDs) are systemic autoimmune
conditions characterized by frequent lung involvement. This usually takes the form of …

Introduction: Systemic lupus erythematosus [SLE] is a chronic, autoimmune condition
characterized by the formation of autoantibodies directed against nuclear components and …

Organ damage is a key determinant of poor long‐term prognosis and early death in patients
with systemic lupus erythematosus (SLE). Prevention of damage is a key treatment goal of …